Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
NWPX Infrastructure Inc
NWPX
$1.12B
| $1.13M | ﹤0.01% |
122,900
+18,400
| +18% | +$170K |
|
2527
UTStarcom
UTSI
$23M
| $1.13M | ﹤0.01% |
153,949
+1,900
| +1% | +$16.2K |
|
|
MIXT
2528
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $1.13M | ﹤0.01% |
286,891
+96,991
| +51% | +$370K |
|
|
GFA
2529
DELISTED
Gafisa S.A.
GFA
| $1.13M | ﹤0.01% |
59,119
+9,071
| +18% | +$149K |
|
|
CSLT
2530
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.13M | ﹤0.01% |
339,400
+159,658
| +89% | +$525K |
|
|
STKL
2531
DELISTED
SunOpta
STKL
| $1.13M | ﹤0.01% |
252,371
+191,841
| +317% | +$1.05M |
|
2532
Scholastic
SCHL
$785M
| $1.13M | ﹤0.01% |
30,101
-14,700
| -33% | -$524K |
|
|
FINL
2533
DELISTED
Finish Line
FINL
| $1.12M | ﹤0.01% |
+53,232
| New | +$986K |
|
2534
Champion Homes
SKY
$5.21B
| $1.12M | ﹤0.01% |
120,900
+17,800
| +17% | +$85.1K |
|
2535
G. Willi-Food International
WILC
$394M
| $1.12M | ﹤0.01% |
597,500
+600
| +0.1% | +$2.41K |
|
|
ALBO
2536
DELISTED
Albireo Pharma Inc
ALBO
| $1.12M | ﹤0.01% |
113,170
+15,020
| +15% | +$134K |
|
2537
LKQ Corp
LKQ
$6.42B
| $1.12M | ﹤0.01% |
35,060
-278,800
| -89% | -$7.78M |
|
2538
Compugen
CGEN
$226M
| $1.11M | ﹤0.01% |
199,490
-79,136
| -28% | -$413K |
|
|
ESND
2539
DELISTED
Essendant Inc.
ESND
| $1.11M | ﹤0.01% |
34,822
-46,400
| -57% | -$1.37M |
|
2540
STAAR Surgical
STAA
$1.28B
| $1.11M | ﹤0.01% |
150,400
+136,200
| +959% | +$922K |
|
2541
Veru
VERU
$45.5M
| $1.11M | ﹤0.01% |
59,400
+1,950
| +3% | +$34.1K |
|
2542
NNN REIT
NNN
$8.91B
| $1.11M | ﹤0.01% |
24,000
-27,500
| -53% | -$1.19M |
|
2543
Diana Shipping
DSX
$309M
| $1.1M | ﹤0.01% |
589,866
+175,930
| +43% | +$324K |
|
|
SHLM
2544
DELISTED
Schulman (A.) Inc
SHLM
| $1.1M | ﹤0.01% |
40,441
-88,900
| -69% | -$2.23M |
|
2545
Franklin Covey
FC
$222M
| $1.1M | ﹤0.01% |
62,400
+6,400
| +11% | +$109K |
|
2546
Dr. Reddy's Laboratories
RDY
$10.2B
| $1.1M | ﹤0.01% |
121,500
-232,000
| -66% | -$2.07M |
|
|
HPJ
2547
DELISTED
Highpower International Inc
HPJ
| $1.1M | ﹤0.01% |
587,100
+9,800
| +2% | +$22.1K |
|
2548
TriNet
TNET
$3.15B
| $1.09M | ﹤0.01% |
+76,300
| New | +$1.08M |
|
|
IIN
2549
DELISTED
IntriCon Corporation
IIN
| $1.09M | ﹤0.01% |
171,500
+1,500
| +0.9% | +$10.1K |
|
2550
M/I Homes
MHO
$3.87B
| $1.08M | ﹤0.01% |
58,200
-89,156
| -61% | -$1.6M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.